Codexis (CDXS) News Today $5.00 +0.08 (+1.63%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Codexis, Inc. (NASDAQ:CDXS) Sees Significant Increase in Short InterestCodexis, Inc. (NASDAQ:CDXS - Get Free Report) was the recipient of a large increase in short interest in December. As of December 31st, there was short interest totalling 2,290,000 shares, an increase of 20.5% from the December 15th total of 1,900,000 shares. Based on an average trading volume of 668,900 shares, the short-interest ratio is presently 3.4 days.January 19 at 12:40 AM | marketbeat.com403,667 Shares in Codexis, Inc. (NASDAQ:CDXS) Acquired by Tallon Kerry PatrickTallon Kerry Patrick purchased a new position in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 403,667 shares of the biotechnology company's stock, valued at apJanuary 17, 2025 | marketbeat.comBarclays PLC Purchases 70,255 Shares of Codexis, Inc. (NASDAQ:CDXS)Barclays PLC increased its holdings in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 51.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 207,628 shares of the biotechnology company's stJanuary 17, 2025 | marketbeat.comCodexis appoints new independent directorJanuary 16, 2025 | msn.comCodexis expands board with new director Christos RichardsJanuary 16, 2025 | msn.comCodexis Appoints Christos Richards to Board of DirectorsJanuary 16, 2025 | tipranks.comCodexis Appoints Christos Richards to Board of DirectorsJanuary 16, 2025 | globenewswire.comCodexis (NASDAQ:CDXS) Share Price Crosses Above 200 Day Moving Average - Here's WhyJanuary 14, 2025 | americanbankingnews.comCodexis (NASDAQ:CDXS) Stock Crosses Above Two Hundred Day Moving Average - What's Next?Codexis (NASDAQ:CDXS) Share Price Passes Above 200-Day Moving Average - What's Next?January 14, 2025 | marketbeat.comCodexis Announces New Employment Inducement GrantsJanuary 10, 2025 | globenewswire.comCaribou Biosciences Hires CFO From CodexisJanuary 2, 2025 | marketwatch.comCodexis, Inc. (NASDAQ:CDXS) Short Interest Up 10.5% in DecemberCodexis, Inc. (NASDAQ:CDXS - Get Free Report) was the target of a large increase in short interest in December. As of December 15th, there was short interest totalling 1,900,000 shares, an increase of 10.5% from the November 30th total of 1,720,000 shares. Based on an average trading volume of 660,000 shares, the days-to-cover ratio is currently 2.9 days.January 1, 2025 | marketbeat.comStifel Financial Corp Lowers Stock Holdings in Codexis, Inc. (NASDAQ:CDXS)Stifel Financial Corp lessened its holdings in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 38.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 172,186 shares of the biotechnology company's stock after seDecember 27, 2024 | marketbeat.comCodexis (NASDAQ:CDXS) Stock Price Passes Above 200-Day Moving Average - Time to Sell?Codexis (NASDAQ:CDXS) Shares Cross Above 200-Day Moving Average - Here's What HappenedDecember 19, 2024 | marketbeat.comCodexis, Inc.'s (NASDAQ:CDXS) high institutional ownership speaks for itself as stock continues to impress, up 17% over last weekDecember 14, 2024 | finance.yahoo.comJacobs Levy Equity Management Inc. Sells 114,194 Shares of Codexis, Inc. (NASDAQ:CDXS)Jacobs Levy Equity Management Inc. lessened its holdings in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) by 11.3% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 895,695 shares of thDecember 8, 2024 | marketbeat.comCodexis Announces New Employment Inducement GrantsDecember 6, 2024 | globenewswire.comFred Alger Management LLC Lowers Holdings in Codexis, Inc. (NASDAQ:CDXS)Fred Alger Management LLC lowered its stake in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) by 64.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 125,916 shares of the biotechnology company's stockDecember 2, 2024 | marketbeat.comCodexis, Inc. (NASDAQ:CDXS) Short Interest Down 13.8% in NovemberCodexis, Inc. (NASDAQ:CDXS - Get Free Report) was the target of a large decline in short interest in November. As of November 15th, there was short interest totalling 1,680,000 shares, a decline of 13.8% from the October 31st total of 1,950,000 shares. Based on an average daily volume of 661,400 shares, the short-interest ratio is currently 2.5 days.December 1, 2024 | marketbeat.comCantor Fitzgerald Keeps Their Buy Rating on Codexis (CDXS)November 23, 2024 | markets.businessinsider.comCodexis (NASDAQ:CDXS) Receives Overweight Rating from Cantor FitzgeraldCantor Fitzgerald reissued an "overweight" rating and issued a $11.00 target price on shares of Codexis in a research report on Friday.November 22, 2024 | marketbeat.comCodexis to Participate in Piper Sandler 36th Annual Healthcare ConferenceNovember 19, 2024 | globenewswire.comStifel Nicolaus Remains a Buy on Codexis (CDXS)November 15, 2024 | markets.businessinsider.comCodexis (CDXS) Receives a Hold from TD CowenNovember 15, 2024 | markets.businessinsider.comCodexis (NASDAQ:CDXS) Given Overweight Rating at Cantor FitzgeraldCantor Fitzgerald restated an "overweight" rating and set a $11.00 price objective on shares of Codexis in a report on Friday.November 15, 2024 | marketbeat.comCodexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi TherapeuticsNovember 14, 2024 | globenewswire.comBaillie Gifford & Co. Sells 895,002 Shares of Codexis, Inc. (NASDAQ:CDXS)Baillie Gifford & Co. lessened its position in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) by 33.0% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,813,800 shares of the biotechnology company's stocNovember 14, 2024 | marketbeat.comCodexis, Inc.: Codexis Announces Appointment of Raymond De Vré, PhD, to Board of DirectorsNovember 13, 2024 | finanznachrichten.deCodexis Strengthens Board and Updates BylawsNovember 13, 2024 | markets.businessinsider.comCodexis Announces Appointment of Raymond De Vré, PhD, to Board of DirectorsNovember 12, 2024 | globenewswire.comCodexis (CDXS) Gets a Buy from Craig-HallumNovember 12, 2024 | markets.businessinsider.comCodexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi TherapeuticsNovember 11, 2024 | globenewswire.comCodexis Announces New Employment Inducement GrantsNovember 8, 2024 | globenewswire.comabrdn plc Raises Position in Codexis, Inc. (NASDAQ:CDXS)abrdn plc lifted its holdings in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 62.5% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 800,410 shares of the biotechnology company's stock after acquiring an additional 307,762 shares during the quartNovember 5, 2024 | marketbeat.comCodexis to Participate in Upcoming Healthcare ConferencesNovember 4, 2024 | globenewswire.comCodexis' (CDXS) Hold Rating Reiterated at BenchmarkBenchmark reissued a "hold" rating on shares of Codexis in a research report on Monday.November 4, 2024 | marketbeat.comCodexis Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsNovember 3, 2024 | finance.yahoo.comCodexis, Inc. (NASDAQ:CDXS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.17November 3, 2024 | finance.yahoo.comCodexis (CDXS) Receives a Buy from Stifel NicolausNovember 1, 2024 | markets.businessinsider.comCodexis Inc (CDXS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Focus ...November 1, 2024 | finance.yahoo.comCodexis Reports Strong Q3 Revenue GrowthNovember 1, 2024 | markets.businessinsider.comCodexis: Hold Rating Amid Mixed Market Position and Future Growth ProspectsNovember 1, 2024 | markets.businessinsider.comCodexis Reports Third Quarter 2024 Financial ResultsOctober 31, 2024 | markets.businessinsider.comAssenagon Asset Management S.A. Boosts Stock Position in Codexis, Inc. (NASDAQ:CDXS)Assenagon Asset Management S.A. boosted its position in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 23.4% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,103,442 shares of the biotechnology company's stock after purchasing an adOctober 31, 2024 | marketbeat.comCodexis, Inc. (NASDAQ:CDXS) Short Interest UpdateCodexis, Inc. (NASDAQ:CDXS - Get Free Report) was the recipient of a significant decrease in short interest in the month of October. As of October 15th, there was short interest totalling 2,000,000 shares, a decrease of 11.5% from the September 30th total of 2,260,000 shares. Based on an average daily trading volume, of 552,700 shares, the short-interest ratio is currently 3.6 days.October 29, 2024 | marketbeat.comCodexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual MeetingOctober 24, 2024 | globenewswire.comCodexis (CDXS) to Post Quarterly Earnings on ThursdayCodexis (NASDAQ:CDXS) will be releasing earnings after the market closes on Thursday, October 31, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=634762)October 24, 2024 | marketbeat.comCodexis (NASDAQ:CDXS) Stock Price Crosses Above Two Hundred Day Moving Average - Here's What HappenedCodexis (NASDAQ:CDXS) Stock Crosses Above Two Hundred Day Moving Average - Here's What HappenedOctober 22, 2024 | marketbeat.comCodexis announces employment inducement grantsOctober 15, 2024 | finance.yahoo.comCodexis Announces New Employment Inducement GrantsOctober 14, 2024 | globenewswire.com Get Codexis News Delivered to You Automatically Sign up to receive the latest news and ratings for CDXS and its competitors with MarketBeat's FREE daily newsletter. Email Address CDXS Media Mentions By Week CDXS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CDXS News Sentiment▼0.740.48▲Average Medical News Sentiment CDXS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CDXS Articles This Week▼93▲CDXS Articles Average Week Get Codexis News Delivered to You Automatically Sign up to receive the latest news and ratings for CDXS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CLDX News BCRX News NVAX News INVA News MYGN News OPK News IRWD News EBS News RIGL News XOMA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CDXS) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Codexis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Codexis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDXS Stock Alerts